Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label Extension of ZS-004 for Hyperkalemia
NCT02107092Phase 3Completed
- Sponsor
- ZS Pharma
- Start
- May 2014
- Primary completion
- Jul 2015
- Modality
- DNA Intercalators/Alkylators
- Countries
- 3
01
Overview
A Phase 3 trial of sodium zirconium cyclosilicate in hyperkalemia, sponsored by ZS Pharma. Started May 2014; status: completed.
02
Drugs
sodium zirconium cyclosilicate
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on NCT02107092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02107092.